DE60323235D1 - Pramipexol-tablette mit verzögerter wirkstoffabgabe - Google Patents

Pramipexol-tablette mit verzögerter wirkstoffabgabe

Info

Publication number: DE60323235D1
Authority: DE; Germany
Prior art keywords: pramipexol; tablet; active ingredient; delayed active; delayed
Prior art date: 2002-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60323235T

Other languages

English (en)

Inventor

Gregory E Amidon

Loksidh D Ganorkar

John M Heimlich

Ernest J Lee

Robert M Noack

Joseph P Reo

Connie J Skoug

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim International GmbH

Original Assignee

Pharmacia LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2003-07-25

Publication date

2008-10-09

2003-07-25 Application filed by Pharmacia LLC filed Critical Pharmacia LLC

2008-10-09 Application granted granted Critical

2008-10-09 Publication of DE60323235D1 publication Critical patent/DE60323235D1/de

2023-07-26 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

DE60323235T 2002-07-25 2003-07-25 Pramipexol-tablette mit verzögerter wirkstoffabgabe Expired - Lifetime DE60323235D1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US39844702P	2002-07-25	2002-07-25
US39842702P	2002-07-25	2002-07-25
US47951303P	2003-06-18	2003-06-18
PCT/US2003/023205 WO2004010997A1 (en)	2002-07-25	2003-07-25	Sustained-release tablet composition of pramipexole

Publications (1)

Publication Number	Publication Date
DE60323235D1 true DE60323235D1 (de)	2008-10-09

Family

ID=31192087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60323235T Expired - Lifetime DE60323235D1 (de)	2002-07-25	2003-07-25	Pramipexol-tablette mit verzögerter wirkstoffabgabe

Country Status (41)

Country	Link
US (2)	US20050226926A1 (de)
EP (2)	EP1531814B1 (de)
JP (1)	JP4700963B2 (de)
KR (1)	KR100712832B1 (de)
CN (1)	CN1313092C (de)
AP (1)	AP2201A (de)
AR (1)	AR040681A1 (de)
AT (1)	ATE406162T1 (de)
AU (1)	AU2003261241B2 (de)
BR (1)	BR0312960A (de)
CA (1)	CA2492854C (de)
CR (1)	CR7661A (de)
CU (1)	CU23440B7 (de)
CY (1)	CY1110408T1 (de)
DE (1)	DE60323235D1 (de)
DK (1)	DK1531814T3 (de)
EA (2)	EA009663B1 (de)
EC (1)	ECSP055568A (de)
ES (1)	ES2310673T3 (de)
GE (1)	GEP20074048B (de)
HK (1)	HK10777456A1 (de)
HR (1)	HRP20041235B1 (de)
IL (1)	IL166078A0 (de)
IS (1)	IS7623A (de)
MA (1)	MA27328A1 (de)
ME (1)	MEP52308A (de)
MX (1)	MXPA05001054A (de)
MY (1)	MY138846A (de)
NO (1)	NO334298B1 (de)
NZ (1)	NZ537790A (de)
OA (1)	OA13303A (de)
PA (1)	PA8578301A1 (de)
PE (1)	PE20040130A1 (de)
PL (1)	PL215587B1 (de)
PT (1)	PT1531814E (de)
RS (1)	RS51719B (de)
SI (1)	SI1531814T1 (de)
TW (1)	TWI347849B (de)
UY (1)	UY27912A1 (de)
WO (1)	WO2004010997A1 (de)
ZA (1)	ZA200500439B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2305252A1 (de) *	2001-12-11	2011-04-06	University Of Virginia Patent Foundation	Verwendung von Pramipexol zur Behandlung amyotropher Lateralsklerose
US20060281797A1 (en) *	2001-12-11	2006-12-14	University Of Virginia Patent Foundation	Neurorestoration with R(+) Pramipexole
US20050226926A1 (en)	2002-07-25	2005-10-13	Pfizer Inc	Sustained-release tablet composition of pramipexole
MY136318A (en) *	2002-07-25	2008-09-30	Pharmacia Corp	Sustained-release tablet composition
MY142204A (en) *	2002-07-25	2010-10-29	Pharmacia Corp	Pramipexole once-daily dosage form
CN1823091B (zh)	2003-07-11	2010-05-12	旭化成化学株式会社	功能性淀粉粉末
KR20070050081A (ko) *	2004-08-13	2007-05-14	베링거 인겔하임 인터내셔날 게엠베하	프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
RS52057B2 (sr) *	2004-08-13	2018-03-30	Boehringer Ingelheim Int	Formulacija tablete sa produženim oslobađanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
DE602004022205D1 (de) *	2004-09-09	2009-09-03	Psicofarma S A De C V	Pharmazeutische zusammensetzung für die verzögerte freisetzung von hydralazin und ihre verwendung als unterstützung zur krebstherapie
EP1731514A1 (de) *	2005-06-02	2006-12-13	Sandoz AG	Verfahren zur Herstellung von Pramipexol
JP2009504748A (ja) *	2005-08-15	2009-02-05	ユニバーシティオブバージニアパテントファウンデーション	Ｒ（＋）プラミペキソールを用いた神経回復
WO2007090882A2 (en) *	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Pharmaceutical extended release compositions comprising pramipexole
US20090041844A1 (en) *	2006-02-10	2009-02-12	Boehringer Ingelheim International Gmbh	Modified Release Formulation
WO2007090883A1 (en) *	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Extended release formulation
US8518926B2 (en)	2006-04-10	2013-08-27	Knopp Neurosciences, Inc.	Compositions and methods of using (R)-pramipexole
WO2007121188A2 (en) *	2006-04-10	2007-10-25	Knopp Neurosciences, Inc.	Compositions and methods of using r(+) pramipexole
KR20090021169A (ko) *	2006-05-16	2009-02-27	크놉 뉴로사이언시스 인코포레이티드	Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
WO2008001204A2 (en) *	2006-06-29	2008-01-03	Antares Pharma Ipl Ag	Transdermal compositions of pramipexole having enhanced permeation properties
US8524695B2 (en) *	2006-12-14	2013-09-03	Knopp Neurosciences, Inc.	Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) *	2007-03-14	2010-06-24	ノップニューロサイエンシーズ、インク．	キラル精製置換ベンゾチアゾールジアミンの合成
JP2010525018A (ja) *	2007-04-24	2010-07-22	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	プラミペキソール又はその医薬的に許容できる塩を含有する徐放性錠剤型製剤との組成物
US20080299189A1 (en) *	2007-06-04	2008-12-04	Drugtech Corporation	Controlled release dopamine agonist compositions
WO2009152041A2 (en) *	2008-06-09	2009-12-17	Supernus Pharmaceuticals, Inc.	Controlled release formulations of pramipexole
US20110190356A1 (en)	2008-08-19	2011-08-04	Knopp Neurosciences Inc.	Compositions and Methods of Using (R)- Pramipexole
WO2010148409A1 (en) *	2009-06-19	2010-12-23	Knopp Neurosciences, Inc.	Compositions and methods for treating amyotrophic lateral sclerosis
EP2448411A4 (de) *	2009-07-02	2012-11-28	Supernus Pharmaceuticals Inc	Verfahren zur behandlung einer neurologischen störung
WO2011037976A2 (en) *	2009-09-22	2011-03-31	Dr. Reddy's Laboratories Limited	Pramipexole pharmaceutical formulations
EP2525786A2 (de)	2010-01-18	2012-11-28	Synthon BV	Pramipexoltabletten mit verlängerter freisetzung
TR201001862A1 (tr)	2010-03-11	2011-10-21	Sanovel �La� San.Ve T�C.A.�.	Kontrollü salım gerçekleştiren pramipeksol formülasyonları.
JP2013526601A (ja)	2010-05-24	2013-06-24	ルピン・リミテッド	プラミペキソールの徐放性製剤
KR101307334B1 (ko) *	2010-07-02	2013-09-12	주식회사 바이오파마티스	프라미펙솔 또는 이의 약학적으로 허용되는 염을 포함하는 안정성이 개선된 서방형 약학 조성물
WO2013034173A1 (en)	2011-09-06	2013-03-14	Synthon Bv	Pramipexole extended release tablets
US9512096B2 (en)	2011-12-22	2016-12-06	Knopp Biosciences, LLP	Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
EP2732812A1 (de)	2012-11-15	2014-05-21	Aristo Pharma GmbH	Pramipexol-Retardtablettenformulierung
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
ES3043076T3 (en)	2013-07-12	2025-11-24	Areteia Therapeutics Inc	Treating elevated levels of eosinophils and/or basophils
EP3038467B1 (de)	2013-08-13	2020-07-29	Knopp Biosciences LLC	Zusammensetzungen und verfahren zur behandlung von plasmazellenerkrankungen und prolymphozytischen b-zellen-erkrankungen
US9763918B2 (en)	2013-08-13	2017-09-19	Knopp Biosciences Llc	Compositions and methods for treating chronic urticaria
CN103520128B (zh)	2013-10-12	2018-08-21	石家庄杏林锐步医药科技股份有限公司	一种普拉克索的缓释片剂、制备方法及其用途
IL312486B2 (en)	2017-04-10	2025-05-01	Chase Therapeutics Corp	NK1 antagonist combination and method for treating synucleinopathies
WO2018200387A1 (en)	2017-04-24	2018-11-01	Chase Therapeutics Corporation	Compositions and method for treating depression
KR20200026920A (ko)	2017-06-30	2020-03-11	체이스 테라퓨틱스 코포레이션	우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법
CN109316466B (zh) *	2017-07-31	2022-04-05	深圳翰宇药业股份有限公司	一种盐酸普拉克索缓释制剂及其制备方法
CA3072994A1 (en)	2017-08-17	2019-02-21	Zi-Qiang Gu	Pamoate salt of monoamine anti-parkinson's agents, method of preparation and use thereof
CN113876729B (zh) *	2021-11-11	2023-05-30	南通联亚药业股份有限公司	一种盐酸普拉克索缓释片剂及其制备方法

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US15735A (en) *		1856-09-16		Improvement in harvesters
US2887440A (en) *	1957-08-12	1959-05-19	Dow Chemical Co	Enteric coating
US3845770A (en)	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
JPS58403B2 (ja)	1975-07-24	1983-01-06	武田薬品工業株式会社	Ｌ− アスコルビンサンセイザイノセイゾウホウ
US4140755A (en)	1976-02-13	1979-02-20	Hoffmann-La Roche Inc.	Sustained release tablet formulations
CH649215A5 (de)	1981-04-29	1985-05-15	Hoffmann La Roche	Pharmazeutische praeparate.
SE8103843L (sv)	1981-06-18	1982-12-19	Astra Laekemedel Ab	Farmaceutisk mixtur
US4424235A (en)	1981-09-14	1984-01-03	Hoffmann-La Roche Inc.	Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor
EP0186087B1 (de)	1984-12-22	1989-08-23	Dr. Karl Thomae GmbH	Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel
DE3447075A1 (de) *	1984-12-22	1986-07-03	Dr. Karl Thomae Gmbh, 7950 Biberach	Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
US4738851A (en)	1985-09-27	1988-04-19	University Of Iowa Research Foundation, Inc.	Controlled release ophthalmic gel formulation
US4709712A (en)	1986-10-22	1987-12-01	Dermatalogical Products Of Texas	Polycarboxylic acid polymer gels as protective agents
GB8828020D0 (en)	1988-12-01	1989-01-05	Unilever Plc	Topical composition
US5026559A (en)	1989-04-03	1991-06-25	Kinaform Technology, Inc.	Sustained-release pharmaceutical preparation
US5133974A (en)	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
US5273975A (en)	1989-06-09	1993-12-28	The Upjohn Company	Heterocyclic amines having central nervous system activity
HU210264B (en)	1989-06-09	1995-03-28	Upjohn Co	Process for producing amines of condensed ring-systems containing nitrogen and pharmaceutical compositions containing them
GB9015822D0 (en)	1990-07-18	1990-09-05	Beecham Group Plc	Compositions
US5472712A (en) *	1991-12-24	1995-12-05	Euroceltique, S.A.	Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5656296A (en) *	1992-04-29	1997-08-12	Warner-Lambert Company	Dual control sustained release drug delivery systems and methods for preparing same
US5431920A (en)	1993-09-21	1995-07-11	Merck Frosst, Canada, Inc.	Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
US5458887A (en) *	1994-03-02	1995-10-17	Andrx Pharmaceuticals, Inc.	Controlled release tablet formulation
WO1997004752A1 (en) *	1995-07-26	1997-02-13	Duramed Pharmaceuticals, Inc.	Pharmaceutical compositions of conjugated estrogens and methods for their use
WO1998055107A1 (en)	1997-06-06	1998-12-10	Depomed, Inc.	Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
NZ513456A (en) *	1997-07-01	2003-02-28	Pfizer	Sertraline acetate, L-lactate and L-aspartate, processes for their preparation and their uses in psychotic disorders
US5895663A (en)	1997-07-31	1999-04-20	L. Perrigo Company	Pseudoephedrine hydrochloride extended-release tablets
CA2211778A1 (en) *	1997-08-14	1999-02-14	Francois Carriere	Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
US7153845B2 (en)	1998-08-25	2006-12-26	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US6248358B1 (en)	1998-08-25	2001-06-19	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets and methods of making and using the same
DE69819748T2 (de)	1997-09-12	2004-09-30	Columbia Laboratories (Bermuda) Ltd.	Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US6624200B2 (en)	1998-08-25	2003-09-23	Columbia Laboratories, Inc.	Bioadhesive progressive hydration tablets
US6197339B1 (en) *	1997-09-30	2001-03-06	Pharmacia & Upjohn Company	Sustained release tablet formulation to treat Parkinson's disease
US6056977A (en) *	1997-10-15	2000-05-02	Edward Mendell Co., Inc.	Once-a-day controlled release sulfonylurea formulation
GB9802201D0 (en) *	1998-02-03	1998-04-01	Cerestar Holding Bv	Free-flowable directly compressible starch as binder,disintegrant and filler for compresion tablets and hard gelatine capsules
KR20010034588A (ko) *	1998-03-11	2001-04-25	피터 기딩스	조성물
GB9812426D0 (en)	1998-06-10	1998-08-05	Reckitt & Colmann Prod Ltd	Improvements in or relating to organic compositions
TW407058B (en) *	1998-07-17	2000-10-01	Dev Center Biotechnology	Oral cisapride dosage forms with an extended duration
DE19906290A1 (de)	1999-02-15	2000-08-17	Falk Pharma Gmbh	Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
US7374779B2 (en)	1999-02-26	2008-05-20	Lipocine, Inc.	Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
EE05022B1 (et) *	1999-03-31	2008-06-16	Janssen Pharmaceutica N.V.	Eelthelatineeritud tärklise kasutamine hüdrofiilses kontrollitud vabanemisega preparaadis ja hüdrofiilne kontrollitud vabanemisega preparaat
DE19927688A1 (de)	1999-06-17	2000-12-21	Gruenenthal Gmbh	Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
EP2090312A1 (de)	1999-07-01	2009-08-19	Pharmacia & Upjohn Company LLC	(S,S) Reboxetine zur Behandlung von Aufmerksamkeitsstörungen
AU5060499A (en)	1999-08-04	2001-03-05	Ranbaxy Laboratories Limited	Hydrodynamically balanced oral drug delivery system
US6387403B1 (en)	1999-09-15	2002-05-14	Alza Corporation	Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
AU7620600A (en)	1999-09-30	2001-04-30	General Hospital Corporation, The	Use of pramipexole as a treatment for cocaine craving
US20030180352A1 (en) *	1999-11-23	2003-09-25	Patel Mahesh V.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CA2394222A1 (en) *	1999-12-22	2001-06-28	Pharmacia Corporation	Sustained-release formulation of a cyclooxygenase-2 inhibitor
US6467637B2 (en)	2000-01-27	2002-10-22	The York Group, Inc.	Death care merchandising system
NZ520975A (en)	2000-02-24	2004-03-26	Upjohn Co	New drug combinations containing a norepinephrine reuptake inhibitor and an antimuscarinic agent for treating nervous system disorders
US6277875B1 (en) *	2000-07-17	2001-08-21	Andrew J. Holman	Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
ES2187249B1 (es)	2000-09-18	2004-09-16	Synthon Bv	Procedimiento para la preparacion de 2-amino-6-(alquil)amino-4,5,6,7-tetrahidrobenzotiazoles.
SE0004671D0 (sv)	2000-12-15	2000-12-15	Amarin Dev Ab	Pharmaceutical formulation
DE10138275A1 (de)	2001-08-10	2003-02-27	Boehringer Ingelheim Pharma	Verbindungen zur Beseitigung der Anhedonie
BR0215262A (pt)	2001-12-20	2004-12-28	Pharmacia Corp	Formas de dosagem com liberação sustentada de ordem zero e processo para a fabricação das mesmas
US20050226926A1 (en)	2002-07-25	2005-10-13	Pfizer Inc	Sustained-release tablet composition of pramipexole
JP2005538105A (ja)	2002-07-25	2005-12-15	ファルマシア・コーポレーション	水不溶性ポリマーおよび水溶性の小孔形成物質からなる２層により被覆された固体剤形の製造方法
MY136318A (en) *	2002-07-25	2008-09-30	Pharmacia Corp	Sustained-release tablet composition
MY142204A (en)	2002-07-25	2010-10-29	Pharmacia Corp	Pramipexole once-daily dosage form
US20040121010A1 (en)	2002-10-25	2004-06-24	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
AU2003224467A1 (en)	2003-03-11	2004-09-30	Korea United Pharm, Inc.	Process for the preparing of hardcapsule formulation containing lansoprazole
CA2520321A1 (en)	2003-04-04	2004-10-14	Pharmacia Corporation	Oral extended release compressed tablets of multiparticulates
US20050020589A1 (en)	2003-06-18	2005-01-27	Pfizer Inc.	Sustained-release tablet composition comprising a dopamine receptor agonist
KR20070050081A (ko)	2004-08-13	2007-05-14	베링거 인겔하임 인터내셔날 게엠베하	프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도
RS52057B2 (sr)	2004-08-13	2018-03-30	Boehringer Ingelheim Int	Formulacija tablete sa produženim oslobađanjem koja sadrži pramipeksol ili njegovu farmaceutski prihvatljivu so
WO2006046256A1 (en)	2004-10-27	2006-05-04	Alembic Limited	Extended release formulation of pramipexole dihydrochloride
EP1901720A2 (de)	2005-06-23	2008-03-26	Spherics, Inc.	Verbesserte dosierformen zur behandlung von bewegungsstörungen
EP1901721A1 (de)	2005-06-23	2008-03-26	Spherics, Inc.	Dosierformen von pramipexol mit verzögerter oder verlängerter-verzögerter freisetzung
JP2009504748A (ja)	2005-08-15	2009-02-05	ユニバーシティオブバージニアパテントファウンデーション	Ｒ（＋）プラミペキソールを用いた神経回復
WO2007054976A2 (en)	2005-11-08	2007-05-18	Panacea Biotec Ltd.	Lipid based controlled release pharmaceutical composition
WO2007090883A1 (en)	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Extended release formulation
WO2007090882A2 (en)	2006-02-10	2007-08-16	Boehringer Ingelheim International Gmbh	Pharmaceutical extended release compositions comprising pramipexole
US20090041844A1 (en)	2006-02-10	2009-02-12	Boehringer Ingelheim International Gmbh	Modified Release Formulation
EP1886665A1 (de)	2006-08-01	2008-02-13	Boehringer Ingelheim Pharma GmbH & Co. KG	Gastroretentives Freisetzungssystem

2003
- 2003-07-23 US US10/626,166 patent/US20050226926A1/en not_active Abandoned
- 2003-07-24 PA PA20038578301A patent/PA8578301A1/es unknown
- 2003-07-24 PE PE2003000734A patent/PE20040130A1/es not_active Application Discontinuation
- 2003-07-24 MY MYPI20032784A patent/MY138846A/en unknown
- 2003-07-24 AR AR20030102666A patent/AR040681A1/es unknown
- 2003-07-25 EA EA200500079A patent/EA009663B1/ru not_active IP Right Cessation
- 2003-07-25 TW TW092120406A patent/TWI347849B/zh not_active IP Right Cessation
- 2003-07-25 BR BR0312960-8A patent/BR0312960A/pt not_active IP Right Cessation
- 2003-07-25 EP EP03771807A patent/EP1531814B1/de not_active Expired - Lifetime
- 2003-07-25 WO PCT/US2003/023205 patent/WO2004010997A1/en not_active Ceased
- 2003-07-25 PT PT03771807T patent/PT1531814E/pt unknown
- 2003-07-25 GE GEAP8599A patent/GEP20074048B/en unknown
- 2003-07-25 NZ NZ537790A patent/NZ537790A/en unknown
- 2003-07-25 ME MEP-523/08A patent/MEP52308A/xx unknown
- 2003-07-25 ES ES03771807T patent/ES2310673T3/es not_active Expired - Lifetime
- 2003-07-25 AT AT03771807T patent/ATE406162T1/de active
- 2003-07-25 SI SI200331350T patent/SI1531814T1/sl unknown
- 2003-07-25 OA OA1200500016A patent/OA13303A/en unknown
- 2003-07-25 RS YU20050059A patent/RS51719B/sr unknown
- 2003-07-25 PL PL375696A patent/PL215587B1/pl unknown
- 2003-07-25 DK DK03771807T patent/DK1531814T3/da active
- 2003-07-25 KR KR1020057001392A patent/KR100712832B1/ko not_active Expired - Fee Related
- 2003-07-25 MX MXPA05001054A patent/MXPA05001054A/es active IP Right Grant
- 2003-07-25 AU AU2003261241A patent/AU2003261241B2/en not_active Ceased
- 2003-07-25 EP EP08159203A patent/EP1987832A1/de not_active Withdrawn
- 2003-07-25 HR HRP20041235AA patent/HRP20041235B1/hr not_active IP Right Cessation
- 2003-07-25 JP JP2004524787A patent/JP4700963B2/ja not_active Expired - Fee Related
- 2003-07-25 CN CNB038178737A patent/CN1313092C/zh not_active Expired - Fee Related
- 2003-07-25 DE DE60323235T patent/DE60323235D1/de not_active Expired - Lifetime
- 2003-07-25 AP AP2005003205A patent/AP2201A/xx active
- 2003-07-25 CA CA002492854A patent/CA2492854C/en not_active Expired - Fee Related
- 2003-07-25 EA EA200702187A patent/EA200702187A1/ru unknown
- 2003-07-31 UY UY27912A patent/UY27912A1/es not_active Application Discontinuation
2004
- 2004-12-29 IS IS7623A patent/IS7623A/is unknown
- 2004-12-30 IL IL16607804A patent/IL166078A0/xx unknown
2005
- 2005-01-06 NO NO20050093A patent/NO334298B1/no not_active IP Right Cessation
- 2005-01-17 ZA ZA200500439A patent/ZA200500439B/xx unknown
- 2005-01-24 EC EC2005005568A patent/ECSP055568A/es unknown
- 2005-01-24 CR CR7661A patent/CR7661A/es unknown
- 2005-01-25 CU CU20050018A patent/CU23440B7/es not_active IP Right Cessation
- 2005-01-25 MA MA28066A patent/MA27328A1/fr unknown
- 2005-11-08 HK HK05109947A patent/HK10777456A1/xx unknown
2008
- 2008-10-13 CY CY20081101125T patent/CY1110408T1/el unknown
2010
- 2010-03-03 US US12/716,755 patent/US8399016B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1531814B1 (de)	2008-08-27
NO20050093L (no)	2005-02-24
CU23440B7 (es)	2009-10-16
EA200500079A1 (ru)	2005-06-30
ES2310673T3 (es)	2009-01-16
MA27328A1 (fr)	2005-05-02
OA13303A (en)	2007-04-13
SI1531814T1 (sl)	2008-12-31
CN1313092C (zh)	2007-05-02
JP4700963B2 (ja)	2011-06-15
AU2003261241B2 (en)	2009-06-18
PT1531814E (pt)	2008-10-29
US20050226926A1 (en)	2005-10-13
AR040681A1 (es)	2005-04-13
KR20050062516A (ko)	2005-06-23
US8399016B2 (en)	2013-03-19
DK1531814T3 (da)	2008-10-13
GEP20074048B (en)	2007-02-26
MEP52308A (en)	2011-02-10
MXPA05001054A (es)	2005-04-08
RS20050059A (sr)	2007-08-03
HRP20041235A2 (en)	2005-06-30
EA200702187A1 (ru)	2008-06-30
WO2004010997A1 (en)	2004-02-05
CA2492854A1 (en)	2004-02-05
ATE406162T1 (de)	2008-09-15
CN1671382A (zh)	2005-09-21
ZA200500439B (en)	2006-08-30
PL215587B1 (pl)	2013-12-31
PE20040130A1 (es)	2004-03-06
EA009663B1 (ru)	2008-02-28
TW200418523A (en)	2004-10-01
AP2201A (en)	2011-01-24
US20100316710A1 (en)	2010-12-16
UY27912A1 (es)	2004-02-27
ECSP055568A (es)	2005-04-18
NO334298B1 (no)	2014-01-27
HRP20041235B1 (hr)	2013-07-31
JP2005538106A (ja)	2005-12-15
CR7661A (es)	2005-06-08
MY138846A (en)	2009-07-31
IL166078A0 (en)	2006-01-15
NZ537790A (en)	2005-10-28
BR0312960A (pt)	2005-06-14
PA8578301A1 (es)	2004-07-20
WO2004010997A8 (en)	2005-02-24
EP1987832A1 (de)	2008-11-05
HK10777456A1 (en)	2007-11-30
PL375696A1 (en)	2005-12-12
RS51719B (sr)	2011-10-31
AU2003261241A1 (en)	2004-02-16
KR100712832B1 (ko)	2007-04-30
IS7623A (is)	2004-12-29
CA2492854C (en)	2009-10-20
CY1110408T1 (el)	2015-04-29
EP1531814A1 (de)	2005-05-25
TWI347849B (en)	2011-09-01
AP2005003205A0 (en)	2005-03-31

Publication	Publication Date	Title
DE60323235D1 (de)	2008-10-09	Pramipexol-tablette mit verzögerter wirkstoffabgabe
DE60331153D1 (de)	2010-03-18	Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
ATE374016T1 (de)	2007-10-15	Tablette mit hohem wirkstoffgehalt
ATE383771T1 (de)	2008-02-15	Fungizide wirkstoffkombinationen
DE60319848D1 (de)	2008-04-30	Medikament mit mesenchym-stammzellen
DE60239801D1 (de)	2011-06-01	Analgetika mit verzögerter wirkstoffabgabe
DE60335807D1 (de)	2011-03-03	Amphetaminsalz-formulierung mit verzögerter wirkstofffreigabe
ATE392813T1 (de)	2008-05-15	Fungizide wirkstoffkombination
IS7689A (is)	2005-02-08	Fjölþátta lyfjaskammtaform
NO20053076D0 (no)	2005-06-23	Farmasoytisk formulering med en uloselig aktiv forbindelse.
DK1362582T3 (da)	2008-04-21	Overtrukket fast doseringsform
DE60316323D1 (de)	2007-10-25	Feste pharmazeutische formulierungen mit telmisartan
KR20050009999A (ko)	2005-01-26	약제학적 제제
NL1025068A1 (nl)	2004-06-22	Pyrrolopyrimidinederivaten.
NO20045679D0 (no)	2004-12-28	Nye fysiologisk aktive substanser
DE60331463D1 (de)	2010-04-08	Medizinisches System mit Hülsen
FR2855756B1 (fr)	2005-08-26	Comprime orodispersible multicouche
DE602004026719D1 (de)	2010-06-02	Ür tablette
AU2003238179A8 (en)	2003-12-22	Herbicidally active heterocyclylalkynes
NL1028193A1 (nl)	2005-08-08	Farmaceutisch werkzame verbindingen.
ATE361282T1 (de)	2007-05-15	Indazol-aminoacetonitrilderivate mit pestizider wirkung
NO20044188L (no)	2004-12-03	Kontrollerte frigjoringsdoseformer
DE50304722D1 (de)	2006-10-05	Fungizide Wirkstoffkombinationen
EP1731609A4 (de)	2010-04-07	Rad51-expressionsinhibitor, den inhibitor als wirkstoff enthaltender arzneistoff und nutzung davon
ATE376988T1 (de)	2007-11-15	Dihalo-allyloxy-phenol-derivate mit pestizid- aktivität

Legal Events

Date	Code	Title	Description
2009-09-17	8364	No opposition during term of opposition
2010-09-23	8327	Change in the person/name/address of the patent owner	Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, 55218, DE